Matthew M. Pompeo
Research Subjects
Matthew M. Pompeo has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Aaron L. Featherston
Department of Chemistry, Yale University, New Haven, CT 06520, USA
2 shared publications - Chong Han
Department of Synthetic Molecule Process Chemistry
2 shared publications - David K. Leahy
Biohaven Pharmaceuticals, 215 Church Street, New Haven, Connecticut 06510, United States
2 shared publications - Francis Gosselin
Department of Synthetic Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
2 shared publications - Scott J. Miller
Yale University
2 shared publications - Yongseok Kwon
Seoul National University
2 shared publications
Latest Publications
- 4 November 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (45) , 49731-49740
Anionic Phase-Transfer Catalysis for Constructing Chiral Sulfur Centers via Asymmetric Sulfinimidation
Chiral anion phase-transfer (CAPT) catalysis has emerged as a powerful strategy for asymmetric catalysis, yet its stereocontrol modes remain largely limited to π-face differentiation or enantiotopic bond selection. The ability to exert stereocontrol through enantioselective recognition of heteroatom lone pairs remains underdeveloped, restricting catalytic access to configurationally stable heteroatom-centered stereocenters. Here, we report a CAPT platform that enables asymmetric sulfinimidation through enantioselective halogenation of prochiral sulfur(II) lone pairs, providing direct access to chiral aryl and alkyl sulfinimidate esters with high enantioselectivity. Mechanistic studies and computational investigations confirm that halogenation is the enantiodetermining step, forming a chiral, configurationally stable sulfinimidoyl fluoride intermediate. Enantioselective oxidation of prochiral sulfides indicates that this CAPT lone-pair recognition platform may be more generally applicable to heteroatom lone pairs. These findings establish lone-pair differentiation as a new mode of stereocontrol in CAPT and expand the conceptual scope of chiral anionic catalysis toward the asymmetric synthesis of chiral organosulfur compounds.
- 4 November 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (45) , 49731-49740
Anionic Phase-Transfer Catalysis for Constructing Chiral Sulfur Centers via Asymmetric Sulfinimidation
Chiral anion phase-transfer (CAPT) catalysis has emerged as a powerful strategy for asymmetric catalysis, yet its stereocontrol modes remain largely limited to π-face differentiation or enantiotopic bond selection. The ability to exert stereocontrol through enantioselective recognition of heteroatom lone pairs remains underdeveloped, restricting catalytic access to configurationally stable heteroatom-centered stereocenters. Here, we report a CAPT platform that enables asymmetric sulfinimidation through enantioselective halogenation of prochiral sulfur(II) lone pairs, providing direct access to chiral aryl and alkyl sulfinimidate esters with high enantioselectivity. Mechanistic studies and computational investigations confirm that halogenation is the enantiodetermining step, forming a chiral, configurationally stable sulfinimidoyl fluoride intermediate. Enantioselective oxidation of prochiral sulfides indicates that this CAPT lone-pair recognition platform may be more generally applicable to heteroatom lone pairs. These findings establish lone-pair differentiation as a new mode of stereocontrol in CAPT and expand the conceptual scope of chiral anionic catalysis toward the asymmetric synthesis of chiral organosulfur compounds.
- 31 August 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (9) , 2592-2604
Evolution of a Synthetic Strategy toward Highly Substituted Isoindolinone Glutarimide Fragments
Herein we report the design, development, and evolution of a first-generation synthesis of benzylamine fragment 1·HCl to a second-generation process for 2·HCl en route to highly substituted isoindolinone glutarimide degrader molecules. Salient features of the two syntheses include directed ortho-metalation of substituted benzoic acids, highly regioselective aromatic halogenations, and divergent strategies to install the key aminomethyl motif. The second-generation, stereoselective-enabling process improves on the first-generation route by transitioning from unreliable reactions to robust transformations and proceeding through isolable solid intermediates, thereby enabling improved impurity control.
- 31 August 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (9) , 2592-2604
Evolution of a Synthetic Strategy toward Highly Substituted Isoindolinone Glutarimide Fragments
Herein we report the design, development, and evolution of a first-generation synthesis of benzylamine fragment 1·HCl to a second-generation process for 2·HCl en route to highly substituted isoindolinone glutarimide degrader molecules. Salient features of the two syntheses include directed ortho-metalation of substituted benzoic acids, highly regioselective aromatic halogenations, and divergent strategies to install the key aminomethyl motif. The second-generation, stereoselective-enabling process improves on the first-generation route by transitioning from unreliable reactions to robust transformations and proceeding through isolable solid intermediates, thereby enabling improved impurity control.
- 19 May 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (21) , 6528-6533
Poly(2-pyridyl)phosphines: Separation-Friendly Reagents for the Mitsunobu and Appel Reactions
The use of bis(2-pyridyl)phenylphosphine and tris(2-pyridyl)phosphine as practical, drop-in alternatives to triphenylphosphine in the Mitsunobu and Appel reactions is reported. Their P-oxides are easily purged without chromatography via mild aqueous CuSO4 washes or direct filtration, circumventing the notoriously difficult removal of triphenylphosphine oxide. These orthogonal workup protocols preserve sensitive functionalities, enabling the multigram-scale synthesis of a complex nucleoside and streamlining the preparation of an advanced total synthesis intermediate.
- 19 May 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (21) , 6528-6533
Poly(2-pyridyl)phosphines: Separation-Friendly Reagents for the Mitsunobu and Appel Reactions
The use of bis(2-pyridyl)phenylphosphine and tris(2-pyridyl)phosphine as practical, drop-in alternatives to triphenylphosphine in the Mitsunobu and Appel reactions is reported. Their P-oxides are easily purged without chromatography via mild aqueous CuSO4 washes or direct filtration, circumventing the notoriously difficult removal of triphenylphosphine oxide. These orthogonal workup protocols preserve sensitive functionalities, enabling the multigram-scale synthesis of a complex nucleoside and streamlining the preparation of an advanced total synthesis intermediate.
- 20 May 2024
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 89 (11) , 7618-7629
Umpolung Flow Chemistry for the Synthesis of a 3-Oxo-3H-spiro[benzofuran-2,4′-piperidine] Building Block
An efficient and scalable route to tert-butyl 3-oxo-3H-spiro[benzofuran-2,4'-piperidine]-1'-carboxylate, a central prochiral intermediate in the synthesis of SHP2 inhibitor GDC-1971 (migoprotafib), was achieved. Preparation of the title compound from readily available 2-fluorobenzaldehyde included formation of a modified Katritzky benzotriazole hemiaminal, which, upon deprotonation by n-butyllithium, participated in umpolung reactivity via 1,2-addition to tert-butyl 4-oxopiperidine-1-carboxylate (N-Boc-4-piperidone). Most notably, this reaction was developed as a robust plug-flow process that could be executed on multiple kilograms without the need for pilot-scale reaction vessels operating at low cryogenic temperatures. Treatment of the resulting tetrahedral intermediate with oxalic acid resulted in collapse to the corresponding 4-(2-fluorobenzoyl)-4-hydroxypiperidine, which was isolated as a solid via crystallization. The synthesis concluded with an optimized intramolecular SNAr reaction and final crystallization to generate tert-butyl 3-oxo-3H-spiro[benzofuran-2,4'-piperidine]-1'-carboxylate as a stable, high-quality intermediate suitable for further functionalization toward GDC-1971.
- 20 May 2024
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 89 (11) , 7618-7629
Umpolung Flow Chemistry for the Synthesis of a 3-Oxo-3H-spiro[benzofuran-2,4′-piperidine] Building Block
An efficient and scalable route to tert-butyl 3-oxo-3H-spiro[benzofuran-2,4'-piperidine]-1'-carboxylate, a central prochiral intermediate in the synthesis of SHP2 inhibitor GDC-1971 (migoprotafib), was achieved. Preparation of the title compound from readily available 2-fluorobenzaldehyde included formation of a modified Katritzky benzotriazole hemiaminal, which, upon deprotonation by n-butyllithium, participated in umpolung reactivity via 1,2-addition to tert-butyl 4-oxopiperidine-1-carboxylate (N-Boc-4-piperidone). Most notably, this reaction was developed as a robust plug-flow process that could be executed on multiple kilograms without the need for pilot-scale reaction vessels operating at low cryogenic temperatures. Treatment of the resulting tetrahedral intermediate with oxalic acid resulted in collapse to the corresponding 4-(2-fluorobenzoyl)-4-hydroxypiperidine, which was isolated as a solid via crystallization. The synthesis concluded with an optimized intramolecular SNAr reaction and final crystallization to generate tert-butyl 3-oxo-3H-spiro[benzofuran-2,4'-piperidine]-1'-carboxylate as a stable, high-quality intermediate suitable for further functionalization toward GDC-1971.
- 12 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6530) , 702-707
Catalytic asymmetric and stereodivergent oligonucleotide synthesis
A P catalyst for stereogenic P(III): Phosphodiesters, the key linkage in DNA, RNA, and bioactive oligonucleotide and cyclic nucleotides, are typically synthesized from phosphoramidite precursors. Phosphorothioate linkages, which are more stable, can also be produced this way but have the complication of chirality at the P center, which is synthetically problematic, especially for multiple linkages. Featherston et al. found that two different chiral phosphoric acid catalysts provide stereodivergent synthesis of a stereogenic phosphite intermediate that can be oxidatively modified to the desired stereopure nucleotide derivative. They used this approach in the synthesis of a phosphorothioate derivative of the cyclic dinucleotide 2′,3′-cyclic guanosine monophosphate adenosine monophosphate, which is an important human immune signaling molecule. Science , this issue p. 702
- 12 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6530) , 702-707
Catalytic asymmetric and stereodivergent oligonucleotide synthesis
A P catalyst for stereogenic P(III): Phosphodiesters, the key linkage in DNA, RNA, and bioactive oligonucleotide and cyclic nucleotides, are typically synthesized from phosphoramidite precursors. Phosphorothioate linkages, which are more stable, can also be produced this way but have the complication of chirality at the P center, which is synthetically problematic, especially for multiple linkages. Featherston et al. found that two different chiral phosphoric acid catalysts provide stereodivergent synthesis of a stereogenic phosphite intermediate that can be oxidatively modified to the desired stereopure nucleotide derivative. They used this approach in the synthesis of a phosphorothioate derivative of the cyclic dinucleotide 2′,3′-cyclic guanosine monophosphate adenosine monophosphate, which is an important human immune signaling molecule. Science , this issue p. 702
- Open Access
- 28 October 2020
- Published by American Chemical Society (ACS) in ChemRxiv
Catalytic Asymmetric and Stereodivergent Oligonucleotide Synthesis
We report the catalytic stereocontrolled synthesis of dinucleotides. Chiral phosphoric acid (CPA) catalysts are demonstrated to control the formation of stereogenic phosphorous centers during phosphoramidite transfer for the first time. Unprecedented levels of diastereodivergence are also demonstrated, enabling access to either phosphite diastereomer. Notably, two different CPA scaffolds prove essential for achieving stereodivergence: peptide-embedded phosphothreonine-derived CPAs, which reinforce and amplify the inherent substrate preference, and C2-symmetric BINOL-derived CPAs, which completely overturn this stereochemical preference. The presently reported catalytic method does not require stoichiometric activators or chiral auxiliaries and enables asymmetric catalysis with readily available phosphoramidites. The method was applied to the stereocontrolled synthesis of diastereomeric dinucleotides as well as cyclic dinucleotides (CDNs) which are of broad interest in immono-oncology as agonists of the STING pathway.
- 28 October 2020
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessCatalytic Asymmetric and Stereodivergent Oligonucleotide Synthesis
We report the catalytic stereocontrolled synthesis of dinucleotides. Chiral phosphoric acid (CPA) catalysts are demonstrated to control the formation of stereogenic phosphorous centers during phosphoramidite transfer for the first time. Unprecedented levels of diastereodivergence are also demonstrated, enabling access to either phosphite diastereomer. Notably, two different CPA scaffolds prove essential for achieving stereodivergence: peptide-embedded phosphothreonine-derived CPAs, which reinforce and amplify the inherent substrate preference, and C2-symmetric BINOL-derived CPAs, which completely overturn this stereochemical preference. The presently reported catalytic method does not require stoichiometric activators or chiral auxiliaries and enables asymmetric catalysis with readily available phosphoramidites. The method was applied to the stereocontrolled synthesis of diastereomeric dinucleotides as well as cyclic dinucleotides (CDNs) which are of broad interest in immono-oncology as agonists of the STING pathway.
- Open Access
- 17 August 2019
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 141 (36) , 14411-14420
Total Synthesis and Anti-Cancer Activity of All Known Communesin Alkaloids and Related Derivatives
A unified enantioselective total synthesis and anticancer evaluation of all known epoxide-containing communesin alkaloids and related derivatives is described. Our synthesis is predicated on the convergent and modular diazene-directed assembly of two complex fragments to secure the critical C3a–C3a′ linkage followed by a guided biomimetic aminal reorganization to deliver the heptacyclic core of these alkaloids. Concise enantioselective syntheses of the fragments were devised, with highlights including the application of a rationally designed sulfinamide chiral auxiliary, an efficient calcium trifluoromethanesulfonate promoted intramolecular amination, and a diastereoselective epoxidation that simultaneously converts the new chiral auxiliary to a versatile amine protective group. The modularity of our convergent approach enabled the rapid synthesis of all epoxide-containing members of the communesin family from a single heterodimeric intermediate, including the first total synthesis of communesins C–E, and G–I, and facilitated our stereochemical revision of (−)-communesin I, the most recently isolated communesin alkaloid. Furthermore, the generality of our biogenetically inspired heterodimer rearrangement was demonstrated in a guided synthesis of a communesin derivative with an unnatural topology. Finally, we report the first comparative analysis of the anticancer activities of all naturally occurring communesin alkaloids A–I and eight complex derivatives against five human cancer cell lines. From these data, we have identified (−)-communesin B as the most potent natural communesin and discovered that derivatives with N8′-sulfonamide substitution exhibit up to a 10-fold increase in potency over the natural alkaloids.
- 17 August 2019
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 141 (36) , 14411-14420
Open AccessTotal Synthesis and Anti-Cancer Activity of All Known Communesin Alkaloids and Related Derivatives
A unified enantioselective total synthesis and anticancer evaluation of all known epoxide-containing communesin alkaloids and related derivatives is described. Our synthesis is predicated on the convergent and modular diazene-directed assembly of two complex fragments to secure the critical C3a–C3a′ linkage followed by a guided biomimetic aminal reorganization to deliver the heptacyclic core of these alkaloids. Concise enantioselective syntheses of the fragments were devised, with highlights including the application of a rationally designed sulfinamide chiral auxiliary, an efficient calcium trifluoromethanesulfonate promoted intramolecular amination, and a diastereoselective epoxidation that simultaneously converts the new chiral auxiliary to a versatile amine protective group. The modularity of our convergent approach enabled the rapid synthesis of all epoxide-containing members of the communesin family from a single heterodimeric intermediate, including the first total synthesis of communesins C–E, and G–I, and facilitated our stereochemical revision of (−)-communesin I, the most recently isolated communesin alkaloid. Furthermore, the generality of our biogenetically inspired heterodimer rearrangement was demonstrated in a guided synthesis of a communesin derivative with an unnatural topology. Finally, we report the first comparative analysis of the anticancer activities of all naturally occurring communesin alkaloids A–I and eight complex derivatives against five human cancer cell lines. From these data, we have identified (−)-communesin B as the most potent natural communesin and discovered that derivatives with N8′-sulfonamide substitution exhibit up to a 10-fold increase in potency over the natural alkaloids.